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Background: Although a substantial percentage of patients with rheumatoid arthritis (RA) experience low back
pain, the characteristics of lumbar spine pathology in RA patients has been poorly investigated. In our institutions,
lumbar spine radiographs indicated scoliosis in 26 patients. The present study aimed to clarify the characteristics of
lumbar scoliosis in RA patients.
Methods: This is a retrospective study of 26 RA patients with lumbar scoliosis. Patient characteristics such as
disease duration, disease stage and class according to Steinbrocker's classification, and medication for RA and
osteoporosis were reviewed. Radiologic evaluation of scoliosis was performed at two different time points by
measuring Cobb angles. The progression of scoliosis per year was calculated by dividing the change in Cobb
angles by the number of years. Apical vertebral rotation, lateral listhesis, and the level of the intercrestal line at the
first observation were also measured. The correlation between different factors and changes in the Cobb angles per
year was analyzed.
Results: Majority of the patients had a long disease duration and were classified as stage 3 or 4 according to
Steinbrocker's classification. During the observation period, most patients were treated with glucocorticoids. Unlike
the previous studies on degenerative scoliosis, apical vertebral rotation, lateral listhesis, and the level of the
intercrestal line at initial observation were not significantly related to the progression of scoliosis. Initial Cobb angles
were inversely related to the progression of scoliosis. Patients who were treated with bisphosphonates showed
slower progression of scoliosis.
Conclusions: Our results indicate that the characteristics of lumbar scoliosis in RA patients differ from those of
degenerative lumbar scoliosis. Bone fragility due to the long disease duration, poor control of disease activity, and
osteoporosis is possibly related to its progression.
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Rheumatoid arthritis (RA) is an inflammatory disorder
that affects multiple joints. In addition to the joints of
the extremities, the atlantoaxial ligament of the cervical
spine is often affected by synovial inflammation. Thus,
the involvement of the cervical spine in RA has been* Correspondence: mohishi@ortho.med.kyushu-u.ac.jp
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unless otherwise stated.studied extensively [1]. In contrast, the pathology of the
thoracic and lumbar spine in RA patients has been
poorly studied. More than 30%–50% of RA patients re-
portedly experience back pain and have a higher degree
of disability and depression than those without back pain
[2-4]. Therefore, clarifying the characteristics of lumbar
spine pathology in RA patients is clinically highly rele-
vant. In 1964, Lawrence et al. [5] found an increased
incidence of subluxation, disc narrowing, apophyseal de-
struction, and osteoporosis of the lumbar spine in RA
patients compared with that in non-RA controls. Based
on these criteria, they estimated that rheumatoid
changes were present in the lumbar spines of 3%–5% ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Clinical features of 26 patients with scoliosis
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Figure 1 Disease-modifying antirheumatic drugs used for the
treatment of 26 RA patients. The percentage of the patients using
each drug is shown. SASP/BCL salazosulfapyridine or bucillamine,
MTX methotrexate, Bio biologic agents.
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the radiographs of RA patients indicated scoliosis, which
was defined as a lateral curvature of the spine >10°. We
performed a retrospective study of 26 RA patients who
presented with lumbar scoliosis. By evaluating the radio-
graphic findings and the backgrounds of these patients,
we attempted to determine the pathological characteris-
tics of this condition.
Materials and methods
This retrospective case series included 26 patients with
RA who presented at the National Kyushu Medical Cen-
ter, Kyushu University Hospital, or Kondo Clinic of
Rheumatology. The institutional review boards approved
the study. The most recent radiographs of these RA
patients indicated lumbar scoliosis with a Cobb angle
of ≥10°. Cobb angles in the first and most recent radio-
graphs were measured using supine anteroposterior im-
ages. The changes in the Cobb angles were divided by
the number of years between two time points to evaluate
the yearly progression. Apical vertebral rotation was
measured according to the criteria introduced by Nash
and Moe [6]. Lateral listhesis and the level of the inter-
crestal line were measured as documented elsewhere [7].
Patient characteristics such as age, sex, and disease dur-
ation were reviewed. To evaluate disease control during
the observation period, both disease stage and class ac-
cording to Steinbrocker's classification [8] were assessed.
Medications for both RA and osteoporosis were
reviewed. The destruction of the hip and knee joints was
evaluated using the Larsen method [9]. For statistical
analyses, Mann-Whitney U test or ANOVA was per-
formed. Mann-Whitney U test was used for the com-
parison of the data between two groups, and ANOVA
was used for the comparison of the data between three
groups or more. P < 0.05 was accepted as significant.
Results
Baseline characteristics of the 26 patients are summa-
rized in Table 1. Mean disease duration was 21.8 years,
and 24 patients had disease duration >10 years. Accord-
ing to Steinbrocker's classification, most patients had
advanced stage (stage 3 and stage 4) RA (Table 1). The
disease-modifying antirheumatic drugs that the patients
were taking were methotrexate, sulfasalazine, bucilla-
mine, and biologic agents. Importantly, all but one pa-
tient were taking a glucocorticoid (Figure 1).
The mean Cobb angle at the initial observation was
17.18° ± 9.29°, which progressed to 24.5° ± 10.2° within a
mean 4.32 years (Figure 2). The mean change in the
Cobb angle per year was 1.80°.
Regression analysis between yearly changes in Cobb
angles and initial Cobb angles showed that the scoliosis
of those with larger initial Cobb angles progressed moreslowly (Figure 3). There was a correlation between the
two values (r = −0.505). Those with apical vertebral
rotation ≥ grade 2 tended to show faster progression of
scoliosis, although the difference was not statistically sig-
nificant (Figure 4). Neither lateral listhesis nor the level
of the intercrestal line was correlated with the progres-
sion of scoliosis (data not shown). The majority of our
patients showed erosive changes around the endplates,
whereas proliferative changes were not so evident
(Figure 5). We next investigated the osteoporosis man-
agement of our patients. As shown in Figure 6A, 7 of 26
patients did not receive osteoporosis treatment. The
remaining patients received bisphosphonate (BP) with
or without a vitamin D (VitD) analog (15 patients),
only a VitD analog (3 patients), or a selective estrogen
receptor modulator (SERM) (1 patient) (Figure 6A). The
Figure 2 Progression of scoliosis. Year 0 indicates the first
observation time point.
Figure 4 The relationship between grade of apical vertebral
rotation and change in Cobb angle per year. Error bars
represent means ± SEM.
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in the Cobb angle was 0.70° in the BP treatment group,
3.94° in the VitD treatment group, 1.5° in the SERM
treatment group, and 3.28° in the no treatment group.
Interestingly, when the patients were divided into those
who were treated with and without BP, the former
showed significantly slower progression of scoliosis than
the latter (Figure 6B).
To determine whether the hip and/or knee joint status
affects the progression of scoliosis, we divided the pa-
tients into three groups based on the severity of the hip
and knee joints affected. Group A included those who
underwent joint replacement or joint damage of Larsen
grade 3/4 of the hips and/or knees of the bilateral limbs.
Group B included those with joint replacement or joint
damage of Larsen grade 3/4 of the unilateral lower
limbs. In group A, five patients underwent bilateral total
hip and/or knee replacement, and in group B, sixFigure 3 Regression analysis of Cobb angle at initial
observation and change in Cobb angle per year.
Figure 5 This patient is a 70-year-old woman with RA and
scoliosis with a 24-year history of RA. Progression of scoliosis
and changes of radiological findings were evaluated between 2005
and 2008. The radiographs taken in 2005 (left panels) and 2008
(right panels) are shown. The lines in the anteroposterior views
(upper panels) indicate the upper and lower tilting vertebrae. The
arrows of both anteroposterior and lateral (lower panels) views indicate
progression of disc space narrowing and endplate destruction.
Figure 6 Treatment of osteoporosis and progression of
scoliosis. (A) The progression of scoliosis in each osteoporosis
treatment group is shown. (B) Comparison of scoliosis progression
between those who were treated with BP and those who were not.
Error bars represent means ± SEM. Tx treatment, VitD vitamin D
analog, BP bisphosphonates, SERM selective estrogen receptor
modulator.
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placement. One patient in group B had unilateral knee
joint damage of Larsen grade 4, and 14 had no joint
damage greater than Larsen grade 2 and were catego-
rized as group C. The progression of scoliosis tended to
be faster in group A than in the other groups, although
the difference was not statistically significant (data not
shown).
Discussion
In this study, we investigated the characteristics of lum-
bar scoliosis in RA patients. Previous studies have shown
that a larger initial Cobb angle, a higher grade of apical
vertebral rotation, a greater degree of lateral listhesis,
and the intercrestal line through or below the L4/5 disc
space are predictors of the progression of degenerative
scoliosis [7,10]. In the present study, the initial Cobb
angle was inversely related to the yearly increase in the
Cobb angle, which is contrary to what has been reported
for degenerative scoliosis. Other factors did not show a
statistically significant relationship with scoliosis pro-
gression. These findings suggested that other factors
might be involved in the progression of scoliosis in RA
patients.
Bone fragility is a typical pathological feature of RA
[11]. Although the present study lacks bone mineral
density data, the scoliosis itself would make accurate
measurement difficult. The majority of our patients werealready at either stage 3 or stage 4 according to Stein-
brocker's classification after a long disease duration,
which indicates poor disease control in those patients.
Furthermore, all but one patient were taking a daily dose
of a glucocorticoid. Thus, it is presumable that the bones
of those patients were fragile, and we hypothesize that
bone fragility is part of the pathogenesis of scoliosis in
RA patients. It has been reported by Mawatari et al. [12]
that RA patients can lose substantial vertebral strength
after a mean of 12.2 months. Of note, the bone strength
of the patients treated with alendronate was significantly
higher than that in those who did not receive antiresorp-
tive treatment. It is quite intriguing that, in our study,
patients who were treated with BPs showed significantly
slower progression of scoliosis than those who were not
treated with BPs, which indicates that BP administration
was, at least in part, protective against the progression
of scoliosis. Recent studies have shown that BP is effect-
ive for the management of glucocorticoid-induced osteo-
porosis in terms of fracture prevention [13,14], which
has been reflected in the treatment guidelines for this
condition in different countries [15,16]. Thus, our data
reconfirmed the importance of BP treatment from a per-
spective different from fracture prevention.
In 25 of our patients, we observed erosive changes
around the endplates, which is a typical finding of the
rheumatoid spine [17-21]. With respect to the erosive
changes of the endplates, two different theories have
been proposed. One is the involvement of an inflamma-
tory response in the disc lesion. This theory is supported
by the observation that inflammatory tissue in the
rheumatoid thoracic spine appeared to originate in the
costovertebral articulations and extended into the nearby
discovertebral junction [20]. The other theory is that dis-
covertebral alterations are related to traumatic events
produced by instability in the posterior elements of the
spine. According to the radiographic-pathologic correla-
tive study by Schils et al. [18], no evidence of synovial
infiltration was observed in the disc lesion. A similar re-
sult was reported also by Martel [19], who found react-
ive fibrosis but no inflammation in the destructive lesion
of the discovertebral junction of the cervical spine. Mag-
netic resonance images of 13 of our patients did not
show any obvious signal change of the facet joints or the
endplates, and currently, we do not have evidence that
our patients had facet joint or endplate inflammation
(data not shown).
Disability of the lower extremities, especially the hip
joints, is known to influence lumbar spine degeneration,
which has been documented as hip-spine syndrome [22].
Because RA patients often develop severe hip and/or
knee joint deformity, the effect of both hip and knee joint
destruction on scoliosis progression was studied. Those
who underwent bilateral hip/knee joint replacement
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not, although the difference was not statistically signifi-
cant. Furthermore, because the progression of scoliosis in
those who underwent unilateral total joint replacement or
had severe joint damage of the lower limb was not
affected, the limb length discrepancy per se would not be
related to the progression.
The limitation of the present study is that the number
of patients studied is too small to perform multivariate
analysis. However, scoliosis in RA patients itself is not a
major entity, and it will be extremely difficult to accu-
mulate a large number of patients. Although we used su-
pine anteroposterior radiographs, standing radiographs,
which are standard for the evaluation of scoliosis, would
have shown even more severe deformity. Moreover, in
terms of studying the factors affecting the progression
speed of scoliosis, we believe that our data are still valu-
able because the radiographs were taken under the same
conditions.Conclusions
Our data indicate that the characteristics of the progres-
sion of scoliosis in RA patients differ from those of
degenerative scoliosis. Bone fragility resulting from the
disease activity of RA and glucocorticoid treatment is
possibly related to its progression.
Competing interests
MO received speaking fees from Chugai Pharmaceutical, Ono
Pharmaceutical, Pfizer, Eisai, and Eli Lilly. HM received speaking fees from
Chugai Pharmaceutical, Takeda Pharmaceutical, Mitsubishi-Tanabe Pharma,
Janssen Pharmaceutical, Pfizer, Eisai, Abbott, and Bristol-Myers. MK received
speaking fees from Chugai Pharmaceutical, Takeda Pharmaceutical,
Mitsubishi-Tanabe Pharma, Janssen Pharmaceutical, Pfizer, Eisai, Abbott, and
Bristol-Myers. YN received speaking fees from Chugai Pharmaceutical,
Mitsubishi-Tanabe Pharma, and Abbott. YI received speaking fees from
Chugai Pharmaceutical, Takeda Pharmaceutical, Mitsubishi-Tanabe Pharma,
Janssen Pharmaceutical, Pfizer, Eisai, and Abbott. All fees were less than US
$5,000 each. All other authors declare that they have no competing interests.
Authors' contributions
MO, HM, and MK conceived of the study. MO carried out the data collection
and performed the statistical analysis and drafted the manuscript. MK, KT, YE,
NK, and YN also carried out the data collection. KH, YM, and YI participated
in the design and coordination and helped draft the manuscript. All authors
read and approved the final manuscript.
Acknowledgements
This work was supported in part by a research grant-in-aid from the Ministry
of Education and Science of Japan to MO.
Author details
1Department of Orthopaedic Surgery, Faculty of Medical Sciences, Graduate
School of Medicine, Kyushu University, 3-1-1 Maidashi Higashiku, Fukuoka
812-8582, Japan. 2Department of Orthopaedic Surgery and Rheumatology,
Clinical Research Institute, National Hospital Organization Kyushu Medical
Center, Fukuoka 810-8563, Japan. 3Kondo Clinic of Rheumatology and
Orthopaedics, Fukuoka 810-0001, Japan.
Received: 6 February 2014 Accepted: 9 April 2014
Published: 26 April 2014References
1. Ranawatt CS, O'Leary P, Pellici P, Tsairis P, Marchisello P, Dorr L: Cervical spine
fusion in rheumatoid arthritis. J Bone Joint Surg Am 1979, 61(7):1003–1010.
2. Helliwell PS, Zebouni LN, Porter G, Wright V: A clinical and radiological
study of back pain in rheumatoid arthritis. Br J Rheumatol 1993,
32(3):216–221.
3. Wolfe F: Determinants of WOMAC function, pain and stiffness scores:
evidence for the role of low back pain, symptom counts, fatigue and
depression in osteoarthritis, rheumatoid arthritis and fibromyalgia.
Rheumatology (Oxford) 1999, 38(4):355–361.
4. Kothe R, Kohlmann T, Klink T, Rüther W, Klinger R: Impact of low back pain
on functional limitations, depressed mood and quality of life in patients
with rheumatoid arthritis. Pain 2007, 127(1–2):103–108.
5. Lawrence JS, Sharp J, Ball J, Bier F: Rheumatoid arthritis of the lumbar
spine. Ann Rheum Dis 1964, 23:205–217.
6. Nash CL, Moe JH: A study of vertebral rotation. J Bone Joint Surg Am 1969,
51(2):223–229.
7. Clifford BT: Degenerative lumbar scoliosis: evaluation and management.
J Am Acad Orthop Surg 2003, 11:174–183.
8. Steinbrocker O, Traeger CH, Batterman RC: Therapeutic criteria in
rheumatoid arthritis. J Am Med Assoc 1949, 140(8):659–662.
9. Sokka T: Radiographic scoring in rheumatoid arthritis: a short
introduction to the methods. Bull NYU Hosp Jt Dis 2008, 66(2):166–166.
10. Kohno S, Ikeuchi M, Taniguchi S, Takemasa R, Yamamoto H, Tani T: Factors
predicting progression in early degenerative lumbar scoliosis. J Orthop
Surg 2011, 19(2):141–144.
11. Confavreux CB, Chapurlat RD: Systemic bone effects of biologic therapies
in rheumatoid arthritis and ankylosing spondylitis. Osteoporos Int 2011,
22(4):1023–1036.
12. Mawatari T, Miura H, Hamai S, Shuto T, Nakashima Y, Okazaki K, Kinukawa N,
Sakai S, Hoffmann PF, Iwamoto Y, Keaveny TM: Vertebral strength changes in
rheumatoid arthritis patients treated with alendronate, as assessed by finite
element analysis of clinical computed tomography scans: a prospective
randomized clinical trial. Arthritis Rheum 2008, 58(11):3340–3349.
13. van Staa TP, Geusens P, Zhang B, Leufkens HG, Boonen A, Cooper C: Individual
fracture risk and the cost-effectiveness of bisphosphonates in patients
using oral glucocorticoids. Rheumatology (Oxford) 2007, 46(3):460–466.
14. Reid DM, Devogelaer JP, Roux C: Zoledronic acid and risedronate in the
prevention and treatment of glucocorticoid-induced osteoporosis
(HORIZON): a multicentre, double-blind, double-dummy, randomised
controlled trial. Lancet 2009, 373(9671):1253–1263.
15. Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W, Curtis JR,
Furst DE, McMahon M, Patkar NM, Volkmann E, Saag KG: American College
of Rheumatology 2010 recommendations for the prevention and
treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res
(Hoboken) 2010, 62(11):1515–1526.
16. Nawata H, Soen S, Takayanagi R: Guidelines on the management and
treatment of glucocorticoid-induced osteoporosis of the Japanese
Society for Bone and Mineral Research (2004). J Bone Miner Metab
2005, 23(2):105–109.
17. Resnick D: Thoracolumbar spine abnormalities in rheumatoid arthritis.
Ann Rheum Dis 1978, 37(4):389–391.
18. Schils JP, Resnick D, Haghighi PN, Trudell D, Sartoris DJ: Pathogenesis of
discovertebral and manubriosternal joint abnormalities in rheumatoid
arthritis: a cadaveric study. J Rheumatol 1989, 16(3):291–297.
19. Martel W: Pathogenesis of cervical discovertebral destruction in
rheumatoid arthritis. Arthritis Rheum 1977, 20:1217–1225.
20. Sakai T, Sairyo K, Hamada D, Higashino K, Katoh S, Takata Y, Shinomiya F,
Yasui N: Radiological features of lumbar spinal lesions in patients with
rheumatoid arthritis with special reference to the changes around
intervertebral discs. Spine J 2008, 8(4):605–611.
21. Bywaters EGL: Rheumatoid arthritis in the thoracic region due to spread
from costovertebral joint. Ann Rheum Dis 1974, 33:408–409.
22. Devin CJ, McCullough KA, Morris BJ, Yates AJ, Kang JD: Hip-spine
syndrome. J Am Acad Orthop Surg 2012, 20(7):434–442.
doi:10.1186/1749-799X-9-30
Cite this article as: Ohishi et al.: Characteristics of lumbar scoliosis in
patients with rheumatoid arthritis. Journal of Orthopaedic Surgery and
Research 2014 9:30.
